Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Covid19 Drug Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07254442
What this trial is testing

Investigation of the Impact of Medications Used in COVID-19 Treatment and COVID-19 Vaccine on Hearing

Who this might be right for
HearingCOVID - 19Ototoxicity
Zonguldak Bulent Ecevit University 90
Not applicableStudy completedNCT05304702
What this trial is testing

Lung Injury (Pulmonary Edema) in COVID-19: Treatment With Furosemide and Negative Fluid Balance (NEGBAL)

Who this might be right for
COVID-19
Clinica Colon 120
Not applicableUnknownNCT04568018
What this trial is testing

Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19

Who this might be right for
ARDS Due to COVID-19
Biosurf LLC. 120
Not applicableStudy completedNCT05715593
What this trial is testing

The Effectiveness of a Health Education Intervention to Reduce Anxiety in Quarantined COVID-19 Patients

Who this might be right for
Health Education, COVID-19, Quarantine, Anxiety, Pandemic
University of Monastir 402
Not applicableStudy completedNCT04400006
What this trial is testing

Ozone Therapy in the Prevention of COVID-19 Infection

Who this might be right for
Corona Virus Infection
Marmara University 71
Large-scale testing (Phase 3)Temporarily pausedNCT04310865
What this trial is testing

Yinhu Qingwen Granula for the Treatment of Severe CoVID-19

Who this might be right for
COVID-19Severe PneumoniaChinese Medicine
Zhong Wang 116
Large-scale testing (Phase 3)Study completedNCT04280705
What this trial is testing

Adaptive COVID-19 Treatment Trial (ACTT)

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 1,062
Early research (Phase 1)Ended earlyNCT04385849
What this trial is testing

Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19

Who this might be right for
COVID-19
ImmunityBio, Inc. 1
Not applicableStudy completedNCT04884321
What this trial is testing

Complementary And Alternative Medicine During The COVID-19 Pandemic

Who this might be right for
Complementary Therapies
Hasan Kalyoncu University 3,242
Early research (Phase 1)UnknownNCT04476719
What this trial is testing

The Bioequivalence Study of Umifenovir 200 mg Capsul (ATABAY, Turkey) Under Fasting Conditions

Who this might be right for
Bioequivalence
Atabay Kimya Sanayi Ticaret A.S. 18
Not applicableUnknownNCT04667286
What this trial is testing

Awake Pronation for Covid-19 Treatment

Who this might be right for
Covid-19 Infection
IRCCS Azienda Ospedaliero-Universitaria di Bologna 100
Large-scale testing (Phase 3)Study completedNCT04466241
What this trial is testing

Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial

Who this might be right for
COVID-19COVID-19 Drug TreatmentSevere Acute Respiratory Syndrome Coronavirus 2
ANRS, Emerging Infectious Diseases 294
Large-scale testing (Phase 3)Study completedNCT04317040
What this trial is testing

Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007)

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 234
Testing effectiveness (Phase 2)Ended earlyNCT03331445
What this trial is testing

Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections

Who this might be right for
Respiratory Tract InfectionsCorona Virus Infection
Chris Miller 13
Testing effectiveness (Phase 2)Study completedNCT05077332
What this trial is testing

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

Who this might be right for
2019 Novel Coronavirus Disease2019 Novel Coronavirus Infection2019-nCoV Disease+9 more
Leidos Life Sciences 4
Testing effectiveness (Phase 2)UnknownNCT04502342
What this trial is testing

Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients

Who this might be right for
Covid19
Institute for Research and Development of Medicinal and Food Plants of Guinea 30
Not applicableUnknownNCT04412473
What this trial is testing

COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject's Habits

Who this might be right for
Sars-CoV2
University Hospital, Strasbourg, France 1,000
Large-scale testing (Phase 3)UnknownNCT04913779
What this trial is testing

Safety and Effectiveness of an Immunobiological Drug in CoViD-19

Who this might be right for
COVID-19 PneumoniaCOVID-19 Respiratory InfectionCovid19
Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbran 200
Large-scale testing (Phase 3)Study completedNCT04393246
What this trial is testing

MulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms

Who this might be right for
COVID-19
Cambridge University Hospitals NHS Foundation Trust 454
Large-scale testing (Phase 3)Study completedNCT04330638
What this trial is testing

Treatment of COVID-19 Patients With Anti-interleukin Drugs

Who this might be right for
COVID-19
University Hospital, Ghent 342
Next Page